Community screening for left ventricular systolic dysfunction using plasma and urinary natriuretic peptides

Journal of the American College of Cardiology

Volumn 45, Issue 7, 2005, Pages 1043-1050

  Ng, Leong L ^a,c   Loke, Ian W ^a   Davies, Joan E ^a,b   Geeranavar, Sandeep ^a   Khunti, Kamlesh ^a   Stone, Margaret A ^a   Chin, Derek T ^b   Squire, Iain B ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b GLENFIELD HOSPITAL   (United Kingdom)

^c LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NATRIURETIC FACTOR;

ADULT; AGED; AMINO TERMINAL SEQUENCE; AORTA STENOSIS; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE WALL MOTION; HIGH RISK POPULATION; HUMAN; KIDNEY TUBULE CELL; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; PLASMA; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; ROC CURVE; URINALYSIS; VALVULAR HEART DISEASE;

EID: 15944393568     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.12.058     Document Type: Article

References (10)

1. T.A. McDonagh, S.D. Robb, D.R. Murdoch Biochemical detection of left ventricular systolic dysfunction Lancet 351 1998 9 13
2. F.D.R. Hobbs, R.C. Davis, A.K. Roalfe Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations BMJ 324 2002 1498 1500
3. L.L. Ng, I. Loke, J.E. Davies Identification of previously undiagnosed left ventricular systolic dysfunction: community screening using natriuretic peptides and electrocardiography Eur J Heart Failure 5 2003 775 782
4. S.A. Hunt, D.W. Baker, M.H. Chin ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary J Am Coll Cardiol 38 2001 2101 2113
5. The Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology Guidelines for the diagnosis and treatment of chronic heart failure Eur Heart J 22 2001 1527 1560
6. L.L. Ng, S. Geeranavar, S.C. Jennings, I.W. Loke, R.J. O'Brien Diagnosis of heart failure using urinary natriuretic peptides Clin Sci 106 2003 129 133
7. S.K. Mistry, G.M. Hawksworth, A.D. Struthers, J.S. McLay Differential expression and synthesis of natriuretic peptides determines natriuretic peptide receptor expression in primary cultures of human proximal tubular cells J Hypertens 19 2001 255 262
8. P.A. Heidenreich, M.A. Gubens, G.C. Fonarow, M.A. Konstam, L.W. Stevenson, P.G. Shekelle Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction J Am Coll Cardiol 43 2004 1019 1026
9. K. Totsune, K. Takahashi, F. Satoh Urinary immunoreactive brain natriuretic peptide in patients with renal disease Regul Pept 63 1996 141 147
10. M. Heringlake, C. Heide, L. Bahlmann Effects of tilting and volume loading on plasma levels and urinary excretion of relaxin, NT-pro-ANP, and NT-pro-BNP in male volunteers J Appl Physiol 97 2004 173 179